Dimethyl Sulfoxide

二甲亚砜

Report date: 2024/12/28 20:00:07
NME

Base Information

Drug NameDimethyl Sulfoxide
Drug Alias Name二甲亚碸dimethylis sulfoxidum二甲基亚碸二甲基亚枫二甲基亚砜 +[7] 
ClassificationSmall molecules
Mechanisms of ActionCell membrane permeability enhancers
TargetsNot applicable
Therapy Area/IndicationsPathologic ProcessesCystitis, InterstitialHIV Infections
Global Approved IndicationsCystitis, Interstitial
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1978/04/04
Country/TerritoryUnited StatesUnited KingdomIsrael +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPending
Originator CompaniesMylan Nv
China Registration ClassN/A

Develop Information

Active CompaniesKyorin Pharmaceutical Co LtdMylan Institutional Inc
Inactive CompaniesJiangsu Langyan Life Technology Holdings Co., Ltd.Medicines Development For Global Health LtdAmerican Friends Of Rabin Medical Center Inc
Active IndicationsCystitis, Interstitial
Inactive IndicationsPathologic ProcessesHIV Infections

Other Information

ATC CodeG04BX13M02AX03
Related LinksWikipediaDrugBankKEGG